Janux Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Janux Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Janux Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -8.78 %, a 59.1% increase year-over-year.
  • Janux Therapeutics, Inc. annual Return On Equity for 2023 was -17.9 %, a 4.13% increase from 2022.
  • Janux Therapeutics, Inc. annual Return On Equity for 2022 was -18.7 %, a 58.6% decline from 2021.
  • Janux Therapeutics, Inc. annual Return On Equity for 2021 was -11.8 %, a 121% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -8.78 +12.7 +59.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -13.5 +7.04 +34.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -17.9 +0.77 +4.13% Oct 1, 2023 Dec 31, 2023
Q3 2023 -19.6 -2.27 -13.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -21.5 -6.35 -42% Apr 1, 2023 Jun 30, 2023
Q1 2023 -20.5 -8.73 -73.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -18.7 -6.89 -58.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -17.3 Jul 1, 2022 Sep 30, 2022
Q2 2022 -15.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 -11.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -11.8 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.